| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.029 | 0.5 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.029 | 0.5 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | -0.02 | 0.5 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.02 | 0.5 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |